Open access
Sep 2026
A prospective study evaluating clopidogrel resistance among patients with ischemic cerebrovascular events across different ethnic groups in Israel
Clopidogrel is commonly used for secondary prevention after ischemic cerebrovascular events, but substantial interindividual variability in pharmacodynamics response has been reported. Individuals demonstrating resistance to clopidogrel face a higher likelihood of recurrent ischemic events. This study evaluated clo...
Fadi Shbat, Karine Beiruti Wiegler, N. Dally et al.
· Frontiers in Stroke · 0 citations